Table 1 Donor and recipient characteristics at Baseline of study patients
Total Patients (n = 44) | |
|---|---|
Age (years) | 50 ± 11 |
Male | 27 (61.4%) |
Primary renal diagnosis | |
Hypertension | 11 (25%) |
Diabetes | 11 (25%) |
Glomerulonephritis | 8 (18.2%) |
Unknown cause | 7 (15.9%) |
Others | 7 (15.9%) |
Diabetes (n. %) | 14 (31.8%) |
Prior Transplantation | 2 (4.5%) |
Length of time on hemodialysis (months) | 29 [15–45] |
Panel reactive antibody class I (%) | 0 [0–5] |
Mismatches (n) | 3 [2–3] |
Donor | |
Deceased | 37 (84.1%) |
Living | 7 (15.9%) |
Donor Age (years) | 39 ± 12 |
Cause of Donor Death | |
Cranial trauma | 15 (34%) |
Cerebrovascular | 15 (34%) |
Others | 14 (31%) |
Final donor creatinin (mg/dL) | 1.12 ± 0.6 |
Cold ischemia time (hours) | 22.3 ± 6.2 |
Induction therapy | |
Basiliximab | 12 (27.3%) |
Thymoglobulin | 32 (72.7%) |
Immunosuppression | |
Tacrolimus + mycophenolate + prednisone | 16 (36.4%) |
5 (11.4%) | |
Tacrolimus + sirolimus + prednisone | |
Tacrolimus + everolimus + prednisone | 23 (52.3%) |